The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N'-[1-(4-bromophenyl)-4-formyl-3-phenyl-1H-pyrazol-5-yl]-N,N-dimethyl-methanimidamide ID: ALA1270203
PubChem CID: 52948290
Max Phase: Preclinical
Molecular Formula: C19H17BrN4O
Molecular Weight: 397.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)/C=N/c1c(C=O)c(-c2ccccc2)nn1-c1ccc(Br)cc1
Standard InChI: InChI=1S/C19H17BrN4O/c1-23(2)13-21-19-17(12-25)18(14-6-4-3-5-7-14)22-24(19)16-10-8-15(20)9-11-16/h3-13H,1-2H3/b21-13+
Standard InChI Key: LICHCBXAYIBMKD-FYJGNVAPSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
4.5962 -5.2964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4218 -5.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5842 -4.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8793 -3.9978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2608 -4.5547 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8764 -3.1704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1632 -2.7547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1606 -1.9264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5498 -4.1432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5511 -3.3168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8417 -2.9052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1236 -3.3177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1238 -4.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8381 -4.5539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8469 -5.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4419 -6.6389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8660 -7.3451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6918 -7.3337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0941 -6.6134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6694 -5.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4472 -1.5139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3435 -4.0689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0134 -4.5547 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8728 -1.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4107 -2.9051 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
11 12 2 0
4 6 1 0
12 13 1 0
13 14 2 0
14 9 1 0
6 7 2 0
2 15 1 0
2 3 1 0
15 16 2 0
7 8 1 0
16 17 1 0
3 4 2 0
17 18 2 0
5 9 1 0
18 19 1 0
4 5 1 0
19 20 2 0
20 15 1 0
9 10 2 0
8 21 1 0
5 1 1 0
3 22 1 0
10 11 1 0
22 23 2 0
1 2 2 0
8 24 1 0
12 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.28Molecular Weight (Monoisotopic): 396.0586AlogP: 4.34#Rotatable Bonds: 5Polar Surface Area: 50.49Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.48CX LogP: 4.27CX LogD: 4.22Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.37Np Likeness Score: -1.03
References 1. Cheng KM, Huang YY, Huang JJ, Kaneko K, Kimura M, Takayama H, Juang SH, Wong FF.. (2010) Synthesis and antiproliferative evaluation of N,N-disubstituted-N'-[1-aryl-1H-pyrazol-5-yl]-methnimidamides., 20 (22): [PMID:20855206 ] [10.1016/j.bmcl.2010.08.133 ]